In Person

Discussion of the Current Washington Landscape and Potential Effects for Healthcare and Life Sciences Companies

January 8, 2019
Event details
January 8, 2019
7:30 am
San Francisco, CA

Event summary

The 2018 midterm election results ushered in a divided government in Washington, DC. Healthcare was one of the key issues for many voters, which will make it a priority for both Chambers of Congress. Prescription drug prices, 340B program reform, addressing innovation in the regulatory process, removing regulatory barriers and strengthening the Affordable Care Act are among the topics facing Congress and the Administration.

Please join us for a discussion of how the healthcare and life science industries could be impacted by legislative and oversight agendas, the outlook for regulations and the possibility of cooperation between Capitol Hill and 1600 Pennsylvania Ave.


Wendy Goldstein – Partner, Cooley

Vince Sampson – Special Counsel, Cooley

For more information, please email Amanda Richardson or call +1 617 937 2460.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.